RE:RE:a couple customers WHO CARES!All the market caps in this sector are inflated based on future projections and yet THC Biomed seems to be the only one that gets judged on what their current business is. We don't even have the first quarter of sales in yet, but everyone's made up their mind about it already. BTW you only focus on 4 clones per household, ignoring the fact that medical patients can buy even more and sales to LP start ups. Oh and does everyone keep forgetting that their consulting, training and lab testing was a big part of their previous financials? On top of all this, we know they plan on releasing dried and oils. They will be the most diversified company in this sector.
Maybe we do need a good tree shaking of this stock and leave only the most informed loyal investors. Then when we get rewarded, we can laugh at every person who sold this stock at a loss because it's their own damn faults for not looking harder at this company and condemning it before the first real quarter of sales comes in.
DiligentSon wrote: I don't like you...but I have to agree Let's call it 1 million customers per year, at 4 clones each, $80 per person. I don't know what the profit margins on cloneshipper will be, but for shits and giggles, let's tack on another $20 million(HeII, call it $50million)...$130million in GROSS revenue. Barely enough to support an $1.30 share price...and we haven't subtracted expenses yet. Where do you guys honestly think this clone business is going to take the share price? Give your heads a shake.